Free Trial

Digital Health Acquisition (DHAC) Competitors

Digital Health Acquisition logo
$1.82 -0.11 (-5.70%)
As of 02/21/2025

DHAC vs. ENZ, NIVF, CCM, KDLY, BRTX, MRAI, MGRX, OPGN, SSY, and OTRK

Should you be buying Digital Health Acquisition stock or one of its competitors? The main competitors of Digital Health Acquisition include Enzo Biochem (ENZ), NewGenIvf Group (NIVF), Concord Medical Services (CCM), Kindly MD (KDLY), BioRestorative Therapies (BRTX), Marpai (MRAI), Mangoceuticals (MGRX), OpGen (OPGN), SunLink Health Systems (SSY), and Ontrak (OTRK). These companies are all part of the "healthcare" industry.

Digital Health Acquisition vs.

Digital Health Acquisition (NASDAQ:DHAC) and Enzo Biochem (NYSE:ENZ) are both small-cap unclassified companies, but which is the better stock? We will contrast the two companies based on the strength of their valuation, dividends, risk, institutional ownership, community ranking, earnings, media sentiment, analyst recommendations and profitability.

Digital Health Acquisition has a net margin of 0.00% compared to Enzo Biochem's net margin of -75.34%. Digital Health Acquisition's return on equity of 0.00% beat Enzo Biochem's return on equity.

Company Net Margins Return on Equity Return on Assets
Digital Health AcquisitionN/A N/A N/A
Enzo Biochem -75.34%-7.96%-5.49%

1.0% of Digital Health Acquisition shares are held by institutional investors. Comparatively, 36.9% of Enzo Biochem shares are held by institutional investors. 6.6% of Digital Health Acquisition shares are held by company insiders. Comparatively, 11.4% of Enzo Biochem shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

In the previous week, Enzo Biochem had 1 more articles in the media than Digital Health Acquisition. MarketBeat recorded 1 mentions for Enzo Biochem and 0 mentions for Digital Health Acquisition. Digital Health Acquisition's average media sentiment score of 0.99 beat Enzo Biochem's score of 0.46 indicating that Digital Health Acquisition is being referred to more favorably in the media.

Company Overall Sentiment
Digital Health Acquisition Positive
Enzo Biochem Neutral

Enzo Biochem received 212 more outperform votes than Digital Health Acquisition when rated by MarketBeat users.

CompanyUnderperformOutperform
Digital Health AcquisitionN/AN/A
Enzo BiochemOutperform Votes
212
53.67%
Underperform Votes
183
46.33%

Digital Health Acquisition has higher earnings, but lower revenue than Enzo Biochem.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Digital Health AcquisitionN/AN/AN/AN/AN/A
Enzo Biochem$31.91M0.84-$26.08MN/AN/A

Digital Health Acquisition has a beta of 0.23, meaning that its stock price is 77% less volatile than the S&P 500. Comparatively, Enzo Biochem has a beta of 0.81, meaning that its stock price is 19% less volatile than the S&P 500.

Summary

Enzo Biochem beats Digital Health Acquisition on 6 of the 10 factors compared between the two stocks.

Get Digital Health Acquisition News Delivered to You Automatically

Sign up to receive the latest news and ratings for DHAC and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

DHAC vs. The Competition

MetricDigital Health AcquisitionHolding Offices IndustryUnclassified SectorNASDAQ Exchange
Market Cap$6.56M$469.79M$127.15M$9.14B
Dividend YieldN/A6.99%N/A3.85%
P/E RatioN/A2.231.2119.11
Price / SalesN/A95.779.5976.36
Price / CashN/A69.0193.7934.83
Price / BookN/A4.071.054.62
Net IncomeN/A$35.22M$1.63M$245.85M
7 Day Performance-2.67%-0.65%-0.29%-2.61%
1 Month Performance18.18%-4.74%-1.17%-2.14%
1 Year Performance-84.82%23.41%30.08%12.98%

Digital Health Acquisition Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
DHAC
Digital Health Acquisition
N/A$1.82
-5.7%
N/A-84.6%$6.56MN/A0.002,021Gap Up
ENZ
Enzo Biochem
1.5029 of 5 stars
$0.50
-7.7%
N/A-61.2%$26.28M$31.91M0.00520Analyst Forecast
News Coverage
High Trading Volume
NIVF
NewGenIvf Group
2.28 of 5 stars
$2.19
+12.3%
N/AN/A$22.23M$5.14M0.00N/ANews Coverage
Gap Down
High Trading Volume
CCM
Concord Medical Services
0.6092 of 5 stars
$4.72
-1.0%
N/A-36.2%$20.49M$75.69M0.00970Analyst Forecast
News Coverage
Gap Down
KDLY
Kindly MD
N/A$2.70
-6.6%
N/AN/A$16.15MN/A0.00N/A
BRTX
BioRestorative Therapies
3.1628 of 5 stars
$2.00
-12.7%
$18.00
+800.0%
+32.0%$13.84M$150,000.00-1.317News Coverage
High Trading Volume
MRAI
Marpai
N/A$0.92
+1.1%
$6.00
+552.2%
-33.0%$13.32M$37.15M-0.35150Gap Down
MGRX
Mangoceuticals
0.813 of 5 stars
$4.83
-0.2%
N/A-91.2%$12.03M$730,000.00-0.833News Coverage
Gap Up
OPGN
OpGen
N/A$1.34
-2.9%
N/A-70.2%$11.20M$3.42M0.00100Analyst Forecast
SSY
SunLink Health Systems
N/A$1.02
+6.0%
N/A+18.5%$7.18M$32.44M-9.271,376Analyst Forecast
Gap Down
OTRK
Ontrak
3.1525 of 5 stars
$1.57
-1.3%
$45.00
+2,766.2%
-49.4%$6.63M$12.74M-0.15250Analyst Revision
News Coverage
Gap Up

Related Companies and Tools


This page (NASDAQ:DHAC) was last updated on 2/22/2025 by MarketBeat.com Staff
From Our Partners